4.7 Article

A 12-month projection to September 2022 of the COVID-19 epidemic in the UK using a dynamic causal model

期刊

FRONTIERS IN PUBLIC HEALTH
卷 10, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fpubh.2022.999210

关键词

Coronavirus; post-acute COVID-19 syndrome; incidence; vaccine effectiveness; compartmental models; public health methodology; epidemiology-descriptive

资金

  1. Wellcome [203147]

向作者/读者索取更多资源

While vaccination is effective in preventing COVID-19, it is not sufficient to control the epidemic. Without other public health measures, the UK is projected to experience a significant increase in cases, hospital admissions, and deaths over the next 12 months, posing risks to healthcare services and the economy.
Objectives: Predicting the future UK COVID-19 epidemic allows other countries to compare their epidemic with one unfolding without public health measures except a vaccine program. Methods: A Dynamic Causal Model was used to estimate key model parameters of the UK epidemic, such as vaccine effectiveness and increased transmissibility of Alpha and Delta variants, the effectiveness of the vaccine program roll-out and changes in contact rates. The model predicts the future trends in infections, long-COVID, hospital admissions and deaths. Results: Two-dose vaccination given to 66% of the UK population prevents transmission following infection by 44%, serious illness by 86% and death by 93%. Despite this, with no other public health measures used, cases will increase from 37 million to 61 million, hospital admissions from 536,000 to 684,000 and deaths from 136,000 to 142,000 over 12 months. A retrospective analysis (conducted after the original submission of this report) allowed a comparison of these predictions of morbidity and mortality with actual outcomes. Conclusion: Vaccination alone will not control the epidemic. Relaxation of mitigating public health measures carries several risks, which include overwhelming the health services, the creation of vaccine resistant variants and the economic cost of huge numbers of acute and chronic cases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据